Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response.

Withdrawn

• Conditions: Neoplasm Metastasis; Lung Neoplasms; Breast Neoplasms; Melanoma

• Registration Number: NCT00184288
• Lead Sponsor: Norwegian University of Science and Technology

Brief Summary

The aim of the study is to investigate the feasibility of in vivo single volume MR spectroscopy in evaluation of treatment response in patients with brain metastases, using 3T MR instrument. In order to optimize and avoid ineffective treatment of patients with brain metastases, in vivo MR spectroscopy can be an useful tool.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-11
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-16
• Primary Completion: 2006-06
• Study Completion: 2010-12
• Status Verified: 2011-10
• Last Update Submitted: 2011-11-01
• Last Update Posted: 2011-11-02

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Clinical diagnosis of brain metastases

Exclusion Criteria

• children
• pregnancy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Norwegian University of Science and Technology, Faculty of Medicine; 🇳🇴 Trondheim, Norway